UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients

Cancers, 2020-04, Vol.12 (4), p.959

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population

Radiology and oncology, 2021-11, Vol.55 (4), p.459-466

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-11, Vol.379 (21), p.2040-2051

2018

Link zum Volltext

Verfügbarkeit prüfen

Human skin: source of and target organ for angiotensin II

Experimental dermatology, 2004-03, Vol.13 (3), p.148-154

2004

Link zum Volltext

Verfügbarkeit prüfen

Short-term inspiratory muscle training potentiates the benefits of aerobic and resistance training in patients undergoing CABG in phase II cardiac rehabilitation program

Revista brasileira de cirurgia cardiovascular : orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular, 2015-07, Vol.30 (4), p.474

2015

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1657-1669

2020

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-01, Vol.38 (3), p.271-280

2020

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS11075-TPS11075

2019

Link zum Volltext

Verfügbarkeit prüfen

Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.11536-11536

2020

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors

Journal of cancer research and clinical oncology, 2023-02, Vol.149 (2), p.791-802

2023

Link zum Volltext

Verfügbarkeit prüfen

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

Journal of antimicrobial chemotherapy, 2010-11, Vol.65 (suppl-4), p.iv41-iv51

2010

Link zum Volltext

Verfügbarkeit prüfen

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

International journal of gynecological cancer, 2020-10, Vol.30 (10), p.1633-1637

2020

Link zum Volltext

Verfügbarkeit prüfen

Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.11503-11503

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.105-105

2018

Link zum Volltext

Verfügbarkeit prüfen

BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response—Preliminary results from the NSCLC cohort

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20550-e20550

2019

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous dual-band ultra-high resolution optical coherence tomography

Optics express, 2007-08, Vol.15 (17), p.10832-10841

2007

Link zum Volltext

Verfügbarkeit prüfen

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab for patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction as second-line therapy: The RAMIRIS study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS4132-TPS4132

2018

Link zum Volltext

Verfügbarkeit prüfen

Visualization of the Basement Membrane Zone of the Bladder by Optical Coherence Tomography: Feasibility of Noninvasive Evaluation of Tumor Invasion

Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.677-681

2008

Link zum Volltext

Verfügbarkeit prüfen

Morgellons in dermatology

Journal der Deutschen Dermatologischen Gesellschaft, 2010-04, Vol.8 (4), p.234-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Psychosomatische Störungen bei kosmetischen Operationen

Journal der Deutschen Dermatologischen Gesellschaft, 2007-09, Vol.5 (9), p.no-no

2007

Link zum Volltext

Verfügbarkeit prüfen

Psychosomatic disturbances and cosmetic surgery

Journal der Deutschen Dermatologischen Gesellschaft, 2007-09, Vol.5 (9), p.736-743

2007

Link zum Volltext

Verfügbarkeit prüfen

Morgellons in der Dermatologie

Journal der Deutschen Dermatologischen Gesellschaft, 2010-04, Vol.8 (4), p.234-242

2010

Link zum Volltext

Verfügbarkeit prüfen

Community-driven development of a modified progression-free survival ratio for precision oncology

ESMO open, 2019, Vol.4 (6), p.e000583-e000583, Article e000583

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients

Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Human skin: source of and target organ for angiotensin II

Short-term inspiratory muscle training potentiates the benefits of aerobic and resistance training in patients undergoing CABG in phase II cardiac rehabilitation program

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up

A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415)

Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST): Survival analysis of a randomized trial after 10 years of follow-up

Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC)

BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response—Preliminary results from the SCLC cohort

BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response—Preliminary results from the NSCLC cohort

Simultaneous dual-band ultra-high resolution optical coherence tomography

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab for patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction as second-line therapy: The RAMIRIS study

Visualization of the Basement Membrane Zone of the Bladder by Optical Coherence Tomography: Feasibility of Noninvasive Evaluation of Tumor Invasion

Morgellons in dermatology

Psychosomatische Störungen bei kosmetischen Operationen

Psychosomatic disturbances and cosmetic surgery

Morgellons in der Dermatologie

Community-driven development of a modified progression-free survival ratio for precision oncology

Suchergebnisse filtern